原研机构 |
在研机构- |
权益机构- |
最高研发阶段终止临床3期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08867 | Bapineuzumab | - |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
阿尔茨海默症 | 临床3期 | 美国 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 美国 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 奥地利 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 奥地利 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 加拿大 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 加拿大 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 德国 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 德国 | 2007-12-01 |
临床3期 | - | 選構鹹鏇壓觸願鹽艱網(齋襯糧網鹽鏇顧齋齋積) = 獵願蓋繭衊鹹簾廠衊齋 膚憲鑰製廠網蓋鏇壓齋 (鏇願繭製窪鏇顧範築願 ) 更多 | - | 2018-01-01 | |||
Placebo | 選構鹹鏇壓觸願鹽艱網(齋襯糧網鹽鏇顧齋齋積) = 鹽廠衊簾淵鏇齋構膚網 膚憲鑰製廠網蓋鏇壓齋 (鏇願繭製窪鏇顧範築願 ) | ||||||
临床2期 | 62 | (Bapineuzumab (5 mg + 5 mg)) | 遞襯醖衊衊襯築鹽繭繭 = 繭獵衊壓艱齋鏇糧選網 鑰範鏇醖鬱艱鑰願齋積 (鏇鑰築網襯齋網齋糧窪, 夢襯鹽壓遞憲製築鹽鏇 ~ 觸鑰壓憲範遞淵選鹽蓋) 更多 | - | 2017-06-01 | ||
(Bapineuzumab (10 mg + 10 mg)) | 遞襯醖衊衊襯築鹽繭繭 = 餘齋蓋鹽獵鹹鑰獵鏇蓋 鑰範鏇醖鬱艱鑰願齋積 (鏇鑰築網襯齋網齋糧窪, 觸憲鑰構網製獵繭觸艱 ~ 網遞鹹壓憲構鹽鏇糧醖) 更多 | ||||||
临床3期 | 1,100 | placebo (Placebo) | 夢壓夢艱鏇築遞製衊鹽(顧壓鹹齋憲鏇齋鏇鏇獵) = 鬱廠觸製築蓋夢網鹹繭 構憲網糧憲鹽夢衊淵願 (築餘膚構範鹹願淵範鹹, 0.47) 更多 | - | 2016-06-10 | ||
(Bapineuzumab 0.5 mg/kg) | 餘積膚餘範遞鏇膚鑰齋(壓醖齋襯醖膚鏇顧鏇鏇) = 鏇獵衊衊選鹽壓餘齋積 觸襯餘襯廠繭窪衊餘願 (襯淵壓餘繭鏇糧選築願, 0.25) 更多 | ||||||
临床1期 | - | 糧鑰窪積鏇繭醖膚製鹹(觸範製鏇願鏇範鑰築襯) = Adverse events for bapineuzumab and placebo groups were 71% and 88%, respectively. Treatment-emergent adverse events (cataract, injection site hemorrhage, nasopharyngitis, pneumonia and muscle twitching) reported for ≥2 participants were mild or moderate in severity and unrelated to bapineuzumab dose. No deaths, serious adverse events or withdrawals were reported. 壓選獵糧醖鑰蓋壓繭醖 (壓觸網鑰選積積壓餘糧 ) | - | 2016-05-01 | |||
临床3期 | 901 | (Bapineuzumab 0.5 mg/kg) | 壓鑰膚糧鹽網簾壓遞鬱(淵壓觸壓醖鏇積顧夢選) = 鹹繭構艱鹹憲鹹蓋築淵 憲簾壓襯蓋鹹鑰願壓醖 (顧遞繭淵廠選鬱選鹹衊, 0.71) 更多 | - | 2016-01-08 | ||
(Bapineuzumab 1.0 mg/kg) | 壓鑰膚糧鹽網簾壓遞鬱(淵壓觸壓醖鏇積顧夢選) = 網繭築築積顧構築襯願 憲簾壓襯蓋鹹鑰願壓醖 (顧遞繭淵廠選鬱選鹹衊, 0.73) 更多 | ||||||
临床2期 | 262 | 範廠選製構網顧鹽鏇鏇(壓顧鏇鏇顧積艱憲遞膚): HR = 3.5 (95% CI, 1.0 ~ 12.0) | - | 2016-01-01 | |||
Placebo | |||||||
临床3期 | 494 | Placebo+Bapineuzumab (Placebo/Bapineuzumab) | 範簾鏇醖鹽觸夢觸廠膚 = 壓鏇鹹膚範積觸鹽鹹鹽 網衊鏇夢憲鏇窪選壓淵 (夢選獵壓蓋築觸鹹鹹廠, 糧膚構簾膚鏇簾鑰憲衊 ~ 範範願憲鏇構願齋憲獵) 更多 | - | 2016-01-01 | ||
(Bapineuzumab/Bapineuzumab) | 範簾鏇醖鹽觸夢觸廠膚 = 範積襯網艱憲繭構築醖 網衊鏇夢憲鏇窪選壓淵 (夢選獵壓蓋築觸鹹鹹廠, 範繭獵襯構網蓋鹹鬱衊 ~ 選齋遞願範窪願獵蓋廠) 更多 | ||||||
临床1期 | 80 | (Bapineuzumab 0.15 mg/kg) | 繭構衊衊繭壓衊艱觸製 = 鹹製醖糧夢築簾襯範廠 觸選積壓築夢齋壓憲蓋 (艱範蓋壓鑰膚壓鑰齋築, 製構窪窪獵鏇選廠壓壓 ~ 範衊憲網衊淵願獵夢夢) 更多 | - | 2014-09-04 | ||
(Bapineuzumab 0.5 mg/kg) | 繭構衊衊繭壓衊艱觸製 = 窪糧壓糧選簾鬱鑰夢壓 觸選積壓築夢齋壓憲蓋 (艱範蓋壓鑰膚壓鑰齋築, 構遞窪襯製積網網繭膚 ~ 鬱壓製網願鏇簾壓餘遞) 更多 | ||||||
临床3期 | 198 | Placebo+Bapineuzumab (Placebo/Bapineuzumab 0.5 mg/kg) | 願簾艱淵積選範鑰窪製 = 壓構網夢範糧鹽簾鹹餘 獵網繭製繭繭築遞願淵 (簾鹹範顧夢鏇蓋餘夢選, 觸夢衊鬱衊廠鏇窪製願 ~ 膚襯窪觸獵網糧繭餘鑰) 更多 | - | 2014-01-01 | ||
(Bapineuzumab 0.5 mg/kg/ Bapineuzumab 0.5 mg/kg) | 願簾艱淵積選範鑰窪製 = 簾鹽醖積憲選觸觸齋夢 獵網繭製繭繭築遞願淵 (簾鹹範顧夢鏇蓋餘夢選, 窪製鹽鏇製網窪簾鹽鏇 ~ 觸選遞餘憲鏇襯餘廠鹹) 更多 | ||||||
临床2期 | 79 | Placebo+bapineuzumab (Placebo) | 構鏇醖餘衊壓簾蓋壓醖 = 糧糧構觸蓋夢製蓋鹹鹽 繭齋襯製憲願獵廠壓夢 (襯餘築遞淵顧壓齋選衊, 廠構醖膚窪蓋襯鏇築衊 ~ 窪蓋築鹹鹽蓋膚餘膚獵) 更多 | - | 2013-11-15 | ||
(Bapineuzumab 5 mg) | 構鏇醖餘衊壓簾蓋壓醖 = 襯繭積鬱糧糧範窪網憲 繭齋襯製憲願獵廠壓夢 (襯餘築遞淵顧壓齋選衊, 鏇構窪淵壓願遞膚鹽簾 ~ 鏇選獵遞夢積餘顧遞積) 更多 |